Oxidative stress and bone mineral density in elderly men: Antioxidant activity of alpha-tocopherol

Free Radical Biology and Medicine

Volumn 47, Issue 5, 2009, Pages 668-673

  Östman, Bengt ^a,b   Michaëlsson, Karl ^a,c   Helmersson, Johanna ^a,d   Byberg, Liisa ^a,c   Gedeborg, Rolf ^a,c   Melhus, Håkan ^c   Basu, Samar ^a,d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Ringerike Sykehus   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Tocopherol; BMD; Bone; Isoprostanes; Osteoporosis; Prostaglandins; Vitamin E

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; PEROXY RADICAL; VITAMIN D;

AGED; ANTIOXIDANT ACTIVITY; BLOOD LEVEL; BONE DENSITY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LUMBAR SPINE; MALE; NORMAL HUMAN; OSTEOLYSIS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; URINALYSIS;

AGED; AGED, 80 AND OVER; ALPHA-TOCOPHEROL; ANTIOXIDANTS; BIOLOGICAL MARKERS; BONE DENSITY; DINOPROST; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

MUS;

EID: 67650716995     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.05.031     Document Type: Letter

References (55)

1. Michaëlsson K., Melhus H., Ferm H., Ahlbom A., and Pedersen N.L. Genetic liability to fractures in the elderly. Arch. Intern. Med. 165 (2005) 1825-1830
2. Slemenda C.W., Christian J.C., Williams C.J., Norton J.A., and Johnston Jr. C.C. Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J. Bone Miner. Res. 6 (1991) 561-567
3. Golden T.R., Hinerfeld D.A., and Melov S. Oxidative stress and aging: beyond correlation. Aging Cell 1 (2002) 117-123
4. Almeida M., Han L., Martin-Millan M., O'Brien C.A., and Manolagas S.C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor-to forkhead box O-mediated transcription. J. Biol. Chem. 282 (2007) 27298-27305
5. Jilka R.L., Weinstein R.S., Parfitt A.M., and Manolagas S.C. Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J. Bone Miner. Res. 22 (2007) 1492-1501
6. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., and Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85 (1990) 632-639
7. Manolagas S.C., and Almeida M. Gone with the Wnts: beta-catenin, T-cell factor, forkhead box O, and oxidative stress in age-dependent diseases of bone, lipid, and glucose metabolism. Mol. Endocrinol. 21 (2007) 2605-2614
8. Halliwell B., and Grootveld M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett. 213 (1987) 9-14
9. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., and Roberts L.J. 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87 (1990) 9383-9387
10. Basu S. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid. Redox Signal. 10 (2008) 1405-1434
11. Kadiiska M.B., Gladen B.C., Baird D.D., Graham L.B., Parker C.E., Ames B.N., Basu S., Fitzgerald G.A., Lawson J.A., Marnett L.J., Morrow J.D., Murray D.M., Plastaras J., Roberts II L.J., Rokach J., Shigenaga M.K., Sun J., Walter P.B., Tomer K.B., Barrett J.C., and Mason R.P. Biomarkers of oxidative stress study. III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic. Biol. Med. 38 (2005) 711-718
12. Morrow J.D. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab. Rev. 32 (2000) 377-385
13. Basu S., Michaëlsson K., Olofsson H., Johansson S., and Melhus H. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun. 288 (2001) 275-279
14. Mangiafico R.A., Malaponte G., Pennisi P., Li Volti G., Trovato G., Mangiafico M., Bevelacqua Y., Mazza F., and Fiore C.E. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects. J. Intern. Med. 261 (2007) 587-596
15. Fairfield K.M., and Fletcher R.H. Vitamins for chronic disease prevention in adults: scientific review. JAMA 287 (2002) 3116-3126
16. Gueguen S., Leroy P., Gueguen R., Siest G., Visvikis S., and Herbeth B. Genetic and environmental contributions to serum retinol and alpha-tocopherol concentrations: the Stanislas Family Study. Am. J. Clin. Nutr. 81 (2005) 1034-1044
17. Traber M.G. Vitamin E regulatory mechanisms. Annu. Rev. Nutr. 27 (2007) 347-362
18. McNaughton S.A., Marks G.C., Gaffney P., Williams G., and Green A. Validation of a food-frequency questionnaire assessment of carotenoid and vitamin E intake using weighed food records and plasma biomarkers: the method of triads model. Eur. J. Clin. Nutr. 59 (2005) 211-218
19. Pratico D., Tangirala R.K., Rader D.J., Rokach J., FitzGerald G.A., and Vitamin E. suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat. Med. 4 (1998) 1189-1192
20. Sodergren E., Cederberg J., Basu S., Vessby B., and Vitamin E. supplementation decreases basal levels of F(2)-isoprostanes and prostaglandin f(2alpha) in rats. J. Nutr. 130 (2000) 10-14
21. Roberts II L.J., Oates J.A., Linton M.F., Fazio S., Meador B.P., Gross M.D., Shyr Y., and Morrow J.D. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic. Biol. Med. 43 (2007) 1388-1393
22. Michaëlsson K., Lithell H., Vessby B., and Melhus H. Serum retinol levels and the risk of fracture. N. Engl. J. Med. 348 (2003) 287-294
23. Olofsson H., Byberg L., Mohsen R., Melhus H., Lithell H., and Michaëlsson K. Smoking and the risk of fracture in older men. J. Bone Miner. Res. 20 (2005) 1208-1215
24. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot. Essent. Fatty Acids 58 (1998) 319-325
25. Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot. Essent. Fatty Acids 58 (1998) 347-352
26. Ohrvall M., Tengblad S., and Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J. Intern. Med. 234 (1993) 53-60
27. Thurnham D.I., Davies J.A., Crump B.J., Situnayake R.D., and Davis M. The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status. Ann. Clin. Biochem. 23 Pt 5 (1986) 514-520
28. Smedman A.E., Gustafsson I.B., Berglund L.G., and Vessby B.O. Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am. J. Clin. Nutr. 69 (1999) 22-29
29. Meagher E.A., Barry O.P., Lawson J.A., Rokach J., and FitzGerald G.A. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285 (2001) 1178-1182
30. Traber M.G., Atkinson J., and Vitamin E. antioxidant and nothing more. Free Radic. Biol. Med. 43 (2007) 4-15
31. Vega D., Maalouf N.M., and Sakhaee K. Clinical review. The role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. J. Clin. Endocrinol. Metab. 92 (2007) 4514-4521
32. Schreck R., and Baeuerle P.A. A role for oxygen radicals as second messengers. Trends Cell Biol. 1 (1991) 39-42
33. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
34. Suda N., Morita I., Kuroda T., and Murota S. Participation of oxidative stress in the process of osteoclast differentiation. Biochim. Biophys. Acta 1157 (1993) 318-323
35. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., and Bravo R. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3 (1997) 1285-1289
36. Lappas M., Permezel M., and Rice G.E. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J. Clin. Endocrinol. Metab. 88 (2003) 1723-1729
37. van Diepen S., Majumdar S.R., Bakal J.A., McAlister F.A., and Ezekowitz J.A. Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation 118 (2008) 1946-1952
38. Law M.R., and Hackshaw A.K. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 315 (1997) 841-846
39. Cappuccio F.P., Meilahn E., Zmuda J.M., and Cauley J.A. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 354 (1999) 971-975
40. Krishnan V., Bryant H.U., and Macdougald O.A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116 (2006) 1202-1209
41. Fujii H., Hamada Y., and Fukagawa M. Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats. Bone 42 (2008) 372-379
42. Lee J.H., Kim H.N., Yang D., Jung K., Kim H.M., Kim H.H., Ha H., and Lee Z.H. Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J. Biol. Chem. 284 (2009) 13725-13734
43. Melhus H., Michaëlsson K., Holmberg L., Wolk A., and Ljunghall S. Smoking, antioxidant vitamins, and the risk of hip fracture. J. Bone Miner. Res. 14 (1999) 129-135
44. Sahni S., Hannan M.T., Blumberg J., Cupples L.A., Kiel D.P., and Tucker K.L. Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study. J. Bone Miner. Res. 24 (2009) 1086-1094
45. Sahni, S.; Hannan, M. T.; Gagnon, D.; Blumberg, J.; Cupples, L. A.; Kiel, D. P.; Tucker, K. L. Protective effect of total and supplemental vitamin C intake on the risk of hip fracture-a 17-year follow-up from the Framingham Osteoporosis Study. Osteoporos. Int. in press, doi:10.1007/s00198-009-0897-y [Electronic publication ahead of print].
46. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., Mecocci P., Senin U., Pacifici R., and Cherubini A. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J. Clin. Endocrinol. Metab. 88 (2003) 1523-1527
47. Pasco J.A., Henry M.J., Wilkinson L.K., Nicholson G.C., Schneider H.G., and Kotowicz M.A. Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women. J. Womens Health (Larchmt) 15 (2006) 295-300
48. Sahni S., Hannan M.T., Blumberg J., Cupples L.A., Kiel D.P., and Tucker K.L. Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study. Am. J. Clin. Nutr. 89 (2009) 416-424
49. Sahni S., Hannan M.T., Gagnon D., Blumberg J., Cupples L.A., Kiel D.P., Tucker K.L., and High vitamin C. intake is associated with lower 4-year bone loss in elderly men. J. Nutr. 138 (2008) 1931-1938
50. Hall S.L., and Greendale G.A. The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif. Tissue Int. 63 (1998) 183-189
51. Morton D.J., Barrett-Connor E.L., Schneider D.L., and Vitamin C. supplement use and bone mineral density in postmenopausal women. J. Bone Miner. Res. 16 (2001) 135-140
52. Wolf R.L., Cauley J.A., Pettinger M., Jackson R., Lacroix A., Leboff M.S., Lewis C.E., Nevitt M.C., Simon J.A., Stone K.L., and Wactawski-Wende J. Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative. Am. J. Clin. Nutr. 82 (2005) 581-588
53. Basu S. Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic. Res. 38 (2004) 105-122
54. Kadiiska M.B., Gladen B.C., Baird D.D., Germolec D., Graham L.B., Parker C.E., Nyska A., Wachsman J.T., Ames B.N., Basu S., Brot N., Fitzgerald G.A., Floyd R.A., George M., Heinecke J.W., Hatch G.E., Hensley K., Lawson J.A., Marnett L.J., Morrow J.D., Murray D.M., Plastaras J., Roberts II L.J., Rokach J., Shigenaga M.K., Sohal R.S., Sun J., Tice R.R., Van Thiel D.H., Wellner D., Walter P.B., Tomer K.B., Mason R.P., and Barrett J.C. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?Free Radic. Biol. Med. 38 (2005) 698-710
55. Byberg L., Melhus H., Gedeborg R., Sundstrom J., Ahlbom A., Zethelius B., Berglund L.G., Wolk A., and Michaelsson K. Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ 338 (2009) b688